CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 332.00
+6.00 (1.84%)
Sep 16, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.47 billion as of September 15, 2026. Its market cap has decreased by -44.56% in one year.
Market Cap
6.47B
Enterprise Value
1.69B
Revenue
3.67B
Ranking
n/a
PE Ratio
92.33
Stock Price
332.00
ChartMarket Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.47B, a decrease of -51.99%. That is a compound annual growth rate of -10.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 6.47B | -18.18% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.53B |
| ADR Biomedical Holdings | 7.46B |
| SUSMED,Inc. | 7.16B |
| Chiome Bioscience | 6.87B |
| MEDINET | 6.78B |
| Cyfuse Biomedical K.K. | 6.65B |
| PRISM BioLab Co.,LTD | 6.14B |
| Noile-Immune Biotech | 6.08B |